OPN-5877

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameOPN-5877
Drug Alias NameOPN-5877
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionHistone acetyltransferase p300 degradersDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders +[4] 
TargetsHistone acetyltransferase p300DNA-binding protein IkarosZinc finger protein Aiolos +[4] 
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpna Bio AG
China Registration ClassN/A

Develop Information

Active CompaniesOpna Bio AG
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A